Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction.

HOME
>
論文・技術情報
>
Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction.

アブストラクト	We read with interest the pharmacovigilance study by Gupta and colleagues, who used the FDA Adverse Event Reporting System (FAERS) to explore the association between tumour necrosis factor (TNF) alpha inhibitors and suicidal behaviors (SB) in patients with hidradenitis suppurativa (HS).
ジャーナル名	Journal of the European Academy of Dermatology and Venereology : JEADV
Pubmed追加日	2020/3/20
投稿者	Raschi, Emanuel; Salvo, Francesco; La Placa, Michelangelo; Poluzzi, Elisabetta; De Ponti, Fabrizio
組織名	Pharmacology Unit, Department of Medical and Surgical Sciences, Alma Mater;Studiorum, University of Bologna, Via Irnerio, 48, 40126, Bologna, Italy.;University of Bordeaux, Inserm, Bordeaux Population Health Research Center, team;Pharmacoepidemiology, UMR 1219, F-33000, Bordeaux, France.;CHU de Bordeaux, Pole de sante Publique, Service de Pharmacologie medicale,;F-33000, Bordeaux, France.;Dermatology Division, Department of Experimental, Diagnostic and Specialty;Medicine, Policlinico S. Orsola-Malpighi, University of Bologna, Italy.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/32191362/